Latest News & Updates

Breaking News

  • 5 minutes ago

  • Simantini Singh Deo

Biogen Receives European Commission Approval For High-Dose SPINRAZA To Treat 5q Spinal Muscular Atrophy, Offering Faster Loading And Extended Maintenance Doses
Breaking News
Biocartis Partners With Mayo Clinic To Develop Rapid Sample-To-Answer Test Aimed At Speeding Treatment Decisions For Breast Cancer Patients

Simantini Singh Deo

Other trending news you may like to read

Biogen Receives European Commission Approval For High-Dose SPINRAZA To Treat 5q Spinal Muscular Atrophy, Offering Faster Loading And Extended Maintenance Doses

Biogen secures EU approval for a high-dose SPINRAZA regimen, offering a more rapid loading phase for patients with SMA.

Simantini Singh Deo

Pharma Now

Biocartis Partners With Mayo Clinic To Develop Rapid Sample-To-Answer Test Aimed At Speeding Treatment Decisions For Breast Cancer Patients

Biocartis teams up with Mayo Clinic to advance an investigational rapid breast cancer test aimed at reducing diagnostic delays.

Simantini Singh Deo

Pharma Now

Achieve Life Sciences Promotes Mark Rubinstein, M.D., To Chief Medical Officer As Company Advances Cytisinicline Toward FDA Review

Achieve Life Sciences confirms Mark Rubinstein, MD, as Chief Medical Officer, strengthening leadership as cytisinicline nears FDA review.

Simantini Singh Deo

Pharma Now

Teva And Royalty Pharma Announce $500M Collaboration To Advance TEV-‘408 For Vitiligo After Promising Early Data; Further Readouts In 2026

Royalty Pharma backs Teva with up to $500M to accelerate clinical development of the anti-IL-15 antibody TEV-408.

Simantini Singh Deo

Pharma Now